Skip to main content
Diamines & Chemicals Ltd. logo

Diamines & Chemicals Ltd. — Investor Relations & Filings

Ticker · DIAMINESQ ISIN · INE591D01014 LEI · 335800AQNIZET87LXI95 BSE.NS Manufacturing
Open in API
Filings indexed 873 across all filing types
Latest filing 2025-05-16 Regulatory Filings
Country IN India
Listing BSE.NS DIAMINESQ

About Diamines & Chemicals Ltd.

https://dacl.co.in/

Diamines & Chemicals Ltd. specializes in the production of ethylene amines and related chemical intermediates. The company’s core product portfolio includes Ethylenediamine (EDA), Diethylenetriamine (DETA), Triethylenetetramine (TETA), Tetraethylenepentamine (TEPA), and Piperazine. These specialty chemicals are utilized across diverse sectors, including pharmaceuticals, agrochemicals, polyamide resins, and water treatment. The firm operates integrated manufacturing facilities designed for the synthesis of high-purity organic compounds. By leveraging advanced chemical processes, it provides essential raw materials for applications in oilfield chemicals, textile auxiliaries, and paper chemicals. The organization maintains a focus on technical excellence and process innovation to meet the stringent requirements of global supply chains.

Recent filings

Filing Released Lang Actions
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-05-16 English
Board Meeting — Financial Results/Dividend/Other business matters
Regulatory Filings Classification · 95% confidence The document is a short notice dated May 16, 2025, addressed to stock exchanges regarding the rescheduling of a Board Meeting originally planned for May 19, 2025, now postponed to May 29, 2025. The meeting is to consider and approve the Audited Financial Results for the quarter and year ended March 31, 2025, and to consider dividend recommendations. The document also mentions the closure of the trading window as per insider trading regulations. The document does not contain any financial data or the actual financial results but is an announcement about the scheduling of a board meeting and related procedural information. The document length is only 2031 characters, which is short and consistent with an announcement rather than a full report. Therefore, this is not the Annual Report (10-K), Earnings Release (ER), or Interim Report (IR) itself, but an announcement related to a board meeting and financial results. It is not a report publication announcement (RPA) because it does not mention the report being published or attached. It is also not a management or governance report. The best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-05-16 English
The Board Meeting to be held on 19/05/2025 has been revised to 29/05/2025 With reference to the earlier announcement dated May 05, 2025 regarding intimation of Board Meeting, which was ....
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges regarding the rescheduling of a Board Meeting originally planned to approve audited financial results and consider dividend recommendations. It references regulatory compliance under SEBI (LODR) regulations and insider trading rules. The document does not contain any financial data or results itself, nor does it include the actual audited financial results or dividend details. It is an announcement about the timing of a Board Meeting and related procedural information, not the meeting materials or financial reports. The document length is only 2031 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance notices that do not fit other categories.
2025-05-16 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-05-05 English
Board Meeting — Financial Results/Dividend/Other business matters
Regulatory Filings Classification · 95% confidence The document is a notice from the company to stock exchanges about an upcoming Board of Directors meeting scheduled for May 19, 2025. The notice mentions that the Board will consider and approve audited financial results for the quarter and year ended March 31, 2025, and possibly recommend a final dividend. The document is short (1575 characters) and serves as an announcement of a meeting rather than containing any financial results or detailed reports. It references compliance with SEBI (LODR) regulations and Regulation 29, which relates to board meetings and disclosures. Since this is an announcement of a board meeting and not the actual report or results, it fits best under Regulatory Filings (RNS), which is the fallback category for such regulatory announcements that do not fit other specific categories.
2025-05-05 English
Diamines & Chemicals Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 ,inter alia, to consider and approve the Audited Financial ....
Board/Management Information Classification · 95% confidence The document is a notice from the company to stock exchanges about an upcoming Board of Directors meeting scheduled for May 19, 2025. The notice states that the Board will consider and approve audited financial results and possibly recommend a final dividend. The document references compliance with SEBI (LODR) regulations and is clearly an announcement of a meeting rather than the meeting materials or the financial results themselves. The document length is short (1575 characters), and it does not contain any financial data or detailed reports. Therefore, it is not an Annual Report, Earnings Release, or Interim Report. It is a notice about a Board meeting, which fits best under Board/Management Information (MANG).
2025-05-05 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.